Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy 7.2mg is the highest-dose option for semaglutide weight management in the UK, approved by the MHRA in January 2026 and available only on private prescription through a registered pharmacy. Private prices for the 7.2mg maintenance dose typically sit at the higher end of the Wegovy price range — broadly in line with the market movement seen since Eli Lilly's pricing changes in 2025, which pushed the wider injectable weight-loss category upward. Semaglutide is a prescription-only medicine, so any legitimate quote you see will reflect a clinical pathway, not a simple product sale.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching for Wegovy 7.2mg prices have already spotted that quotes vary quite a bit between providers. There's a reason for that, and it isn't always the medicine itself. Private weight-loss treatment in the UK is priced per pen, per month, and what sits underneath a headline figure differs considerably from clinic to clinic. Some prices include a consultation fee on top; others charge separately for the prescription or for follow-up clinical reviews when you move to a higher dose. Delivery is sometimes billed as an add-on.
The practical result is that two quotes that look similar on the surface can cost meaningfully different amounts once you've actually reached the 7.2mg stage of treatment. Titration to 7.2mg takes time (starting at 0.25mg and stepping up roughly every four weeks) so by the time you arrive at maintenance, you'll have had multiple clinical reviews and potentially multiple delivery charges if those weren't bundled in from the start. It adds up.
One misconception worth setting aside gently: that a lower headline price means the medicine is the same and the service is interchangeable. The clinical oversight wrapped around a prescription medicine is part of the product. A pharmacist-led review before each repeat order, identity verification and weight checks aren't optional extras, they're what makes a private prescription legitimate. The Wegovy overview on our site explains the full titration pathway if you're still working out which dose stage you're at.
The MHRA approved the dedicated single-dose 7.2mg Wegovy pen on 14 April 2026, making it the highest maintenance option for adults with a BMI of 30 or above, you can read the announcement on GOV.UK. Because this is a newer presentation, private market pricing at this dose is still settling. If you want a full breakdown of what goes into the figure, our page on the cost of Wegovy 7.2mg walks through each component so you know exactly what you are comparing. Reported private prices across the UK market range roughly £149 to £375 per month depending on the dose and provider, the 7.2mg dose sits toward the top of that range.
At nume, there is one price per treatment cycle. That price covers the consultation, the prescription, the medicine and next-working-day DPD delivery. Nothing is added at checkout. We're not the cheapest provider in this market, and that's a deliberate position: running a GPhC-registered pharmacy with same-day clinical review and seven-day aftercare costs more than a stripped-back service. Our current treatment pricing is shown on the weight-loss treatments page, we don't print per-pen figures in editorial copy because they change with clinical and regulatory updates and we'd rather you see the live number.
For broader context on what Wegovy costs at different dose stages, our Wegovy price guide covers the full range from the starter dose upward.
For a prescription-only medicine, price is a reasonable thing to research but a poor basis for the final decision. Semaglutide in its 7.2mg form is a higher-dose medicine with a well-documented tolerability profile, nausea, vomiting, diarrhoea and constipation are the most common side effects across the GLP-1 class, as documented by the NHS semaglutide medicines page. The clinical review before each repeat order exists partly to catch those issues early, adjust the plan where needed, and confirm that continuing at 7.2mg is still the right call for you specifically.
The MHRA has also been clear about the risks of obtaining weight-loss medicines from unverified sellers. Counterfeit pens have been seized in large quantities across the UK, some containing insulin rather than semaglutide. If you are trying to understand what a fair Wegovy 7.2mg price in the UK looks like before you commit to a provider, knowing the legitimate market range helps you spot offers that fall suspiciously short of it. Any pharmacy supplying Wegovy legally should be verifiable on the GPhC pharmacy register. If you can't find it, don't order from it.
A smaller saving on one month's supply isn't the metric that protects your health. Clinical oversight, genuine supply chain and a prescriber who actually reads your file, that's the right test. If you're comparing costs across earlier dose stages too, our pages on Wegovy 1mg pricing and Wegovy 0.5mg in the UK give the same factual breakdown without promotional spin.
If you'd like a prescriber to review whether Wegovy 7.2mg is the appropriate next step for you, our consultation is free and reviewed the same working day. Speak to our prescribers, no waiting list, no referral needed, clinical assessment required before anything is dispensed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.